Background Smoking and e-cigarette use are strongly associated, but it is currently unclear whether this association is causal, or due to shared factors that influence both behaviours such as a shared genetic liability. The aim of this study was to investigate whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes. Methods PRS of smoking initiation were calculated for young adults (aged 23 to 26 years) of European ancestry in the Avon Longitudinal Study of Parents and Children using the GWAS & Sequencing Consortium of Alcohol and Nicotine use (GSCAN) summary statistics. Five thresholds ranging from 5 × 10-8 to 0.5 were used to calculate five PRS for each individual. Using logistic regression, we investigated the association between smoking initiation PRS and both self-reported smoking initiation and self-reported e-cigarette use, as well as a number of negative control outcomes (socioeconomic position at birth, externalising disorders in childhood and risk-taking in young adulthood). Results We observed positive associations of similar magnitude between smoking initiation PRS and both smoking initiation (OR = 1.29, 95% CI 1.19 to 1.39) and ever e-cigarette use (OR = 1.24, 95% CI 1.14 to 1.34) by the age of 24 years. At lower p-value thresholds, we observed an association between smoking initiation PRS and ever e-cigarette use among never smokers. We also found evidence of associations between smoking initiation PRS and some negative control outcomes, particularly when less stringent p-value thresholds were used but also at the strictest threshold (e.g., gambling, number of sexual partners, conduct disorder at 7 years, and parental socioeconomic position at birth). Conclusions Our results indicate that there may be a shared genetic aetiology between smoking and e-cigarette use, and also with socioeconomic position, externalising disorders in childhood, and risky behaviour more generally. Taken together, this indicates that there may be a common genetic vulnerability to both smoking and e-cigarette use, which may reflect a broad risk-taking phenotype.
Background: Genetic variants which determine amount of coffee consumed have been identified in genome-wide association studies (GWAS) of coffee consumption; these may help to further understanding of the effects of coffee on health outcomes.However, there is limited information about how these variants relate to caffeinated beverage consumption more generally.Aims: To improve phenotype definition for coffee consumption related genetic risk scores by testing their association with coffee, tea and other beverages. Methods:We tested the associations of genetic risk scores for coffee consumption with beverage consumption in 114,316 individuals of European ancestry from the UK Biobank. Drinks were self-reported in a baseline questionnaire and in detailed 24 dietary recall questionnaires in a subset.Results: Genetic risk scores including two and eight single nucleotide polymorphisms (SNPs) explained up to 0.39%, 0.19% and 0.77% of the variance in coffee, tea and combined coffee and tea consumption respectively. A one standard deviation increase in the 8 SNP genetic risk score was associated with a 0.13 cup per day (95% CI: 0.12, 0.14), 0.12 cup per day (95%CI: 0.11, 0.14) and 0.25 cup per day (95% CI: 0.24, 0.27) increase in coffee, tea and combined tea and coffee consumption, respectively. Genetic risk scores also demonstrated positive associations with both caffeinated and decaffeinated coffee and tea consumption. In 48,692 individuals with dietary recall data, the genetic risk scores were positively associated with coffee and tea, (apart from herbal teas) consumption, but did not show clear evidence for positive associations with other beverages. However, there was evidence that the genetic risk scores were associated with lower daily water consumption and lower overall drink consumption.3 Conclusions: Genetic risk scores created from variants identified in coffee consumption GWAS associate more broadly with caffeinated beverage consumption and also with decaffeinated coffee and tea consumption.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.